CVR: 43007068
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity amounted to DKK -15,353,766.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Solid Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -1,687,751, and the net result was DKK -4,355,625.
As of August 28, 2025, John Sørensen Haurum is registered as adm. dir. of Solid Therapeutics ApS.
As of August 28, 2025, Anne Mette Hyldgaard Trauelsen has stepped down as adm. dir. of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,213,656, and the net result was DKK -6,758,207.
Solid Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -2,738,806, and the net result was DKK -3,483,115.
As of December 7, 2023, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -397,812, and the net result was DKK -796,818.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as adm. dir. of Solid Therapeutics ApS.
As of February 1, 2023, John Sørensen Haurum has stepped down as director of Solid Therapeutics ApS.
As of February 1, 2023, Stine Helene Falsig Petersen is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of February 1, 2023, is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 21, 2022, John Sørensen Haurum is registered as director of Solid Therapeutics ApS.
As of February 21, 2022, Claus Haase has stepped down as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Thue Walter Schwartz has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase is registered as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of January 21, 2022, Receptor Holding ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Frimurer Holdings ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Haase Invest ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
Solid Therapeutics ApS was founded on January 21, 2022.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk